Literature DB >> 1085413

Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults.

W K Lau, L S Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085413     DOI: 10.1056/NEJM197609232951308

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  In vitro activities of several diaminomethylpyridopyrimidines against Mycobacterium avium complex.

Authors:  C M Shoen; O Choromanska; R C Reynolds; J R Piper; C A Johnson; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

2.  Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole.

Authors:  T B Vree; Y A Hekster; A M Baars; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 3.  Prevention of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats.

Authors:  R M Kluge; D M Spaulding; A J Spain
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

Review 5.  Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.

Authors:  H F Vöhringer; K Arastéh
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

6.  Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.

Authors:  F R Sattler; J S Remington
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

7.  In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.

Authors:  A Carr; B Tindall; R Penny; D A Cooper
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

8.  Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia.

Authors:  R T Dorr; J R Powell; M Heick; D W Barry
Journal:  Postgrad Med J       Date:  1981-02       Impact factor: 2.401

9.  Pharmacokinetics and adverse effects of 20-mg/kg/day trimethoprim and 100-mg/kg/day sulfamethoxazole in healthy adult subjects.

Authors:  R C Stevens; S C Laizure; C L Williams; D S Stein
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 10.  Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects.

Authors:  C U Tuazon; A M Labriola
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.